2021
DOI: 10.1016/j.chroma.2021.462043
|View full text |Cite
|
Sign up to set email alerts
|

Capillary isoelectric focusing with UV fluorescence imaging detection enables direct charge heterogeneity characterization of erythropoietin drug products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 11 publications
0
6
0
Order By: Relevance
“…CIEF and iCIEF have matured into techniques that are routinely applied in analytical laboratories, especially in the biopharmaceutical industry. Exemplary applications include, but are not limited to, monoclonal antibodies [192,[209][210][211][212][213][214][215], bispecific antibodies [216][217][218], ADCs [219,220], PEGylated proteins [221,222], glycoproteins, in particular erythropoietin [213,223,224], and fusion proteins [213,225]. Because this subsection is part of the former "proteins" section, which was extended to all biopharmaceuticals, it should not go unmentioned that the range of applications has been expanded beyond proteins and includes oligosaccharides [226], LNPs and related mRNA vaccines [227][228][229][230], virus-like particles [231,232], poliovirus [230,233], adeno-associated virus [230,[234][235][236][237], papillomavirus [238], and bacteria and yeast cells [230].…”
Section: Cief and Iciefmentioning
confidence: 99%
See 1 more Smart Citation
“…CIEF and iCIEF have matured into techniques that are routinely applied in analytical laboratories, especially in the biopharmaceutical industry. Exemplary applications include, but are not limited to, monoclonal antibodies [192,[209][210][211][212][213][214][215], bispecific antibodies [216][217][218], ADCs [219,220], PEGylated proteins [221,222], glycoproteins, in particular erythropoietin [213,223,224], and fusion proteins [213,225]. Because this subsection is part of the former "proteins" section, which was extended to all biopharmaceuticals, it should not go unmentioned that the range of applications has been expanded beyond proteins and includes oligosaccharides [226], LNPs and related mRNA vaccines [227][228][229][230], virus-like particles [231,232], poliovirus [230,233], adeno-associated virus [230,[234][235][236][237], papillomavirus [238], and bacteria and yeast cells [230].…”
Section: Cief and Iciefmentioning
confidence: 99%
“…Urea is still one of the most used additives to prevent precipitation [192, 209–211, 216, 219, 223, 224, 267, 268]. However, several other substances have proven their usefulness.…”
Section: Proteins and Biopharmaceuticalsmentioning
confidence: 99%
“…The pretreatment process must be carried out before analyzing recombinant human erythropoietin (rhEPO) drug products (DPs) by general analysis methods because of their complex composition. Nevertheless, an imaged capillary isoelectric focusing‐UV fluorescence imaging detection method could be used for the direct detection of rhEPO in DPs without pretreatment [53]. The applicability of the method was confirmed by evaluating eight different commercial rhEPO‐DPs with a concentration of 2000–10 000 IU/mL.…”
Section: Applicationsmentioning
confidence: 99%
“…In a recent publication, Li et al. reported the use of FL detection to monitor charge variants of low levels of erythropoietin in simulated drug product formulations [37]. Another drawback of CIEF technology is lack of resolution among co‐formulated molecules with similar p I values.…”
Section: Introductionmentioning
confidence: 99%
“…The conventional iCIEF and IEX assays using UV detection lack the needed sensitivity [36] and dynamic range to simultaneously quantify charge variants of multiple components in wide ratios, such as FDC products with ratios ranging from 1:6 to 1:40. In a recent publication, Li et al reported the use of FL detection to monitor charge variants of low levels of erythropoietin in simulated drug product formulations [37]. Another drawback of CIEF technology is lack of resolution among co-formulated molecules with similar pI values.…”
Section: Introductionmentioning
confidence: 99%